Filing Details
- Accession Number:
- 0001225208-18-000493
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-03 19:53:19
- Reporting Period:
- 2017-12-29
- Accepted Time:
- 2018-01-03 19:53:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1483882 | P. Michael Phalen | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp & President, Medsurg | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-29 | 15,835 | $7.16 | 113,745 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-29 | 15,835 | $25.25 | 97,910 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-01 | 13,341 | $0.00 | 111,251 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-01 | 4,578 | $24.79 | 106,673 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-29 | 15,835 | $0.00 | 15,835 | $7.16 |
| Common Stock | Performance Share Units | Disposition | 2018-01-01 | 13,341 | $0.00 | 13,341 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-02-28 | No | 4 | M | Direct | |
| 0 | 2017-12-31 | 2017-12-31 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.24 to $25.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2015 adjusted free cash flow measured against its 2015 financial plan over the one-year performance period ending December 31, 2015 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2016, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2017.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
- Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Billionaire Hedge Funds
